ProMIS Neurosciences, Inc.
PMN
$14.37
$1.8414.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.73M | -8.24M | -10.67M | -11.58M | -10.12M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 408.90K | 189.40K | 197.60K | 197.10K | 212.00K |
| Change in Net Operating Assets | 935.70K | -4.33M | 1.19M | 1.33M | 6.05M |
| Cash from Operations | -10.39M | -12.38M | -9.28M | -10.06M | -3.85M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -700.00 | -- | -- |
| Cash from Investing | -- | -- | -700.00 | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 70.08M | -- | 20.25M | -- |
| Repurchase of Common Stock | -- | -- | -10.17M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 10.17M | 697.70K | -- |
| Cash from Financing | 0.00 | 70.08M | 0.00 | 20.94M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.39M | 57.70M | -9.28M | 10.89M | -3.85M |